Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that the Board of Directors has fixed Thursday, 13th September, 2018 as the Record Date for determining the entitlement of members to receive Bonus Shares. The Bonus Shares, once allotted, shall rank pari-passu in all respects with and carry the same rights as the existing Equity Shares and shall be entitled to participate in full in any dividend and other corporate action, recommended and declared after the new Equity Shares are allotted.
The above information is a part of company’s filings submitted to BSE.
